Sutro Biopharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell STRO and other ETFs, options, and stocks.About STRO
Sutro Biopharma, Inc. engages in the drug discovery, development and manufacture of pharmaceutical products. It focuses on the next generation cancer and autoimmune therapeutics.
CEOJane Chung
CEOJane Chung
Employees338
Employees338
HeadquartersSouth San Francisco, California
HeadquartersSouth San Francisco, California
Founded2003
Founded2003
Employees338
Employees338
STRO Key Statistics
Market cap99.85M
Market cap99.85M
Price-Earnings ratio-0.41
Price-Earnings ratio-0.41
Dividend yield—
Dividend yield—
Average volume120.57K
Average volume120.57K
High today$11.83
High today$11.83
Low today$10.66
Low today$10.66
Open price$10.79
Open price$10.79
Volume48.08K
Volume48.08K
52 Week high$21.50
52 Week high$21.50
52 Week low$5.23
52 Week low$5.23
Stock Snapshot
As of today, Sutro Biopharma(STRO) shares are valued at $11.72. The company's market cap stands at 99.85M, with a P/E ratio of -0.41.
On 2026-01-14, Sutro Biopharma(STRO) stock traded between a low of $10.66 and a high of $11.83. Shares are currently priced at $11.72, which is +9.9% above the low and -0.9% below the high.
Sutro Biopharma(STRO) shares are trading with a volume of 48.08K, against a daily average of 120.57K.
During the past year, Sutro Biopharma(STRO) stock moved between $5.23 at its lowest and $21.50 at its peak.
During the past year, Sutro Biopharma(STRO) stock moved between $5.23 at its lowest and $21.50 at its peak.
Analyst ratings
50%
of 10 ratingsBuy
50%
Hold
40%
Sell
10%
People also own
Based on the portfolios of people who own STRO. This list is generated using Robinhood data, and it’s not a recommendation.